Speech Disturbances in Patients With Dystonia or Chorea Due to Neurometabolic Disorders
Identifieur interne : 000957 ( PascalFrancis/Corpus ); précédent : 000956; suivant : 000958Speech Disturbances in Patients With Dystonia or Chorea Due to Neurometabolic Disorders
Auteurs : Constance Flamand-Rouviere ; Emilie Guettard ; Caroline Moreau ; Nadia Bahi-Buisson ; Vassili Valayannopoulos ; David Grabli ; Jacques Motte ; Diana Rodriguez ; Agathe Roubertie ; Lisa Maintigneux ; Isabelle Kemlin ; Irène Ceballos-Picot ; David Adams ; Marie Vidailhet ; Emmanuel RozeSource :
- Movement disorders [ 0885-3185 ] ; 2010.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
Speech disturbances are frequent and potentially disabling in patients with dystonia or chorea due to neurometabolic disorders (DCND), but their precise characteristics are poorly documented. We prospectively studied 29 consecutive patients with DCND. A detailed description of their speech patterns was obtained by using the Frenchay dysarthria assessment test and the apraxia of speech evaluation test of Wertz. Gross motor function and intelligibility were each scored on 5-point scales to identify a possible correlation between the severity of the speech and motor disorders. All the patients were found to have complex speech alterations with combined features of hyperkinetic dysarthria and speech apraxia. We also noted a correlation between the severity of the speech disorders and the motor disorders. These findings have important implications for speech rehabilitation, and may provide new insights into the pathophysiology of dystonia due to neurometabolic disorders.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 10-0413281 INIST |
---|---|
ET : | Speech Disturbances in Patients With Dystonia or Chorea Due to Neurometabolic Disorders |
AU : | FLAMAND-ROUVIERE (Constance); GUETTARD (Emilie); MOREAU (Caroline); BAHI-BUISSON (Nadia); VALAYANNOPOULOS (Vassili); GRABLI (David); MOTTE (Jacques); RODRIGUEZ (Diana); ROUBERTIE (Agathe); MAINTIGNEUX (Lisa); KEMLIN (Isabelle); CEBALLOS-PICOT (Irène); ADAMS (David); VIDAILHET (Marie); ROZE (Emmanuel) |
AF : | Service de Neurologie, CHU de Bicêtre, AP-HP/Le Kremlin Bicêtre/France (1 aut., 10 aut., 13 aut.); Service de médecine physique et de réadaptation, Hôpital Fernand Widal, AP-HP/Paris/France (2 aut.); Service de neurologie et pathologie du mouvement, IMPRT, Lille EA 2683, IFR 114/France (3 aut.); Service Neurologie Pédiatrique et Maladies métaboliques, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP/Paris/France (4 aut., 5 aut.); Commission Mouvements Anormaux, de la Société Française de Neurologie Pédiatrique/France (4 aut., 15 aut.); Centre de Référence des Maladies Héréditaires du Métabolisme, Hôpital Necker Enfants Malades, Université Paris-Descartes/Paris/France (5 aut.); Pôle des maladies du système nerveux, Fédération de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP/Paris/France (6 aut., 14 aut., 15 aut.); Unité de neurologie pédiatrique, American Memorial Hospital, CHU Reims/France (7 aut.); Service de neuropédiatrie, Université Pierre et Marie Curie, Paris VI, Hôpital Armand Trousseau, AP-HP/Paris/France (8 aut., 11 aut.); Service de Neurologie Pédiatrique, CHU/Montpellier/France (9 aut.); Service de Biochimie Métabolique, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP/Paris/France (12 aut.); Centre d'Investigation Clinique, 9503, INSERM, AP-HP/Paris/France (15 aut.); CNRS UMRS 952, INSERM UMR 7224, Université Pierre et Marie Curie Paris VI/Paris/France (15 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2010; Vol. 25; No. 11; Pp. 1605-1611; Bibl. 35 ref. |
LA : | Anglais |
EA : | Speech disturbances are frequent and potentially disabling in patients with dystonia or chorea due to neurometabolic disorders (DCND), but their precise characteristics are poorly documented. We prospectively studied 29 consecutive patients with DCND. A detailed description of their speech patterns was obtained by using the Frenchay dysarthria assessment test and the apraxia of speech evaluation test of Wertz. Gross motor function and intelligibility were each scored on 5-point scales to identify a possible correlation between the severity of the speech and motor disorders. All the patients were found to have complex speech alterations with combined features of hyperkinetic dysarthria and speech apraxia. We also noted a correlation between the severity of the speech disorders and the motor disorders. These findings have important implications for speech rehabilitation, and may provide new insights into the pathophysiology of dystonia due to neurometabolic disorders. |
CC : | 002B17; 002B17H |
FD : | Dystonie; Syndrome choréique; Pathologie du système nerveux; Parole; Homme |
FG : | Syndrome extrapyramidal; Mouvement involontaire; Pathologie du muscle strié; Trouble neurologique; Pathologie de l'encéphale; Pathologie du système nerveux central |
ED : | Dystonia; Chorea; Nervous system diseases; Speech; Human |
EG : | Extrapyramidal syndrome; Involuntary movement; Striated muscle disease; Neurological disorder; Cerebral disorder; Central nervous system disease |
SD : | Distonía; Corea síndrome; Sistema nervioso patología; Habla; Hombre |
LO : | INIST-20953.354000192608100110 |
ID : | 10-0413281 |
Links to Exploration step
Pascal:10-0413281Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Speech Disturbances in Patients With Dystonia or Chorea Due to Neurometabolic Disorders</title>
<author><name sortKey="Flamand Rouviere, Constance" sort="Flamand Rouviere, Constance" uniqKey="Flamand Rouviere C" first="Constance" last="Flamand-Rouviere">Constance Flamand-Rouviere</name>
<affiliation><inist:fA14 i1="01"><s1>Service de Neurologie, CHU de Bicêtre, AP-HP</s1>
<s2>Le Kremlin Bicêtre</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Guettard, Emilie" sort="Guettard, Emilie" uniqKey="Guettard E" first="Emilie" last="Guettard">Emilie Guettard</name>
<affiliation><inist:fA14 i1="02"><s1>Service de médecine physique et de réadaptation, Hôpital Fernand Widal, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Moreau, Caroline" sort="Moreau, Caroline" uniqKey="Moreau C" first="Caroline" last="Moreau">Caroline Moreau</name>
<affiliation><inist:fA14 i1="03"><s1>Service de neurologie et pathologie du mouvement, IMPRT, Lille EA 2683, IFR 114</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bahi Buisson, Nadia" sort="Bahi Buisson, Nadia" uniqKey="Bahi Buisson N" first="Nadia" last="Bahi-Buisson">Nadia Bahi-Buisson</name>
<affiliation><inist:fA14 i1="04"><s1>Service Neurologie Pédiatrique et Maladies métaboliques, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="05"><s1>Commission Mouvements Anormaux, de la Société Française de Neurologie Pédiatrique</s1>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Valayannopoulos, Vassili" sort="Valayannopoulos, Vassili" uniqKey="Valayannopoulos V" first="Vassili" last="Valayannopoulos">Vassili Valayannopoulos</name>
<affiliation><inist:fA14 i1="04"><s1>Service Neurologie Pédiatrique et Maladies métaboliques, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="06"><s1>Centre de Référence des Maladies Héréditaires du Métabolisme, Hôpital Necker Enfants Malades, Université Paris-Descartes</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Grabli, David" sort="Grabli, David" uniqKey="Grabli D" first="David" last="Grabli">David Grabli</name>
<affiliation><inist:fA14 i1="07"><s1>Pôle des maladies du système nerveux, Fédération de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Motte, Jacques" sort="Motte, Jacques" uniqKey="Motte J" first="Jacques" last="Motte">Jacques Motte</name>
<affiliation><inist:fA14 i1="08"><s1>Unité de neurologie pédiatrique, American Memorial Hospital, CHU Reims</s1>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rodriguez, Diana" sort="Rodriguez, Diana" uniqKey="Rodriguez D" first="Diana" last="Rodriguez">Diana Rodriguez</name>
<affiliation><inist:fA14 i1="09"><s1>Service de neuropédiatrie, Université Pierre et Marie Curie, Paris VI, Hôpital Armand Trousseau, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Roubertie, Agathe" sort="Roubertie, Agathe" uniqKey="Roubertie A" first="Agathe" last="Roubertie">Agathe Roubertie</name>
<affiliation><inist:fA14 i1="10"><s1>Service de Neurologie Pédiatrique, CHU</s1>
<s2>Montpellier</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Maintigneux, Lisa" sort="Maintigneux, Lisa" uniqKey="Maintigneux L" first="Lisa" last="Maintigneux">Lisa Maintigneux</name>
<affiliation><inist:fA14 i1="01"><s1>Service de Neurologie, CHU de Bicêtre, AP-HP</s1>
<s2>Le Kremlin Bicêtre</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kemlin, Isabelle" sort="Kemlin, Isabelle" uniqKey="Kemlin I" first="Isabelle" last="Kemlin">Isabelle Kemlin</name>
<affiliation><inist:fA14 i1="09"><s1>Service de neuropédiatrie, Université Pierre et Marie Curie, Paris VI, Hôpital Armand Trousseau, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ceballos Picot, Irene" sort="Ceballos Picot, Irene" uniqKey="Ceballos Picot I" first="Irène" last="Ceballos-Picot">Irène Ceballos-Picot</name>
<affiliation><inist:fA14 i1="11"><s1>Service de Biochimie Métabolique, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Adams, David" sort="Adams, David" uniqKey="Adams D" first="David" last="Adams">David Adams</name>
<affiliation><inist:fA14 i1="01"><s1>Service de Neurologie, CHU de Bicêtre, AP-HP</s1>
<s2>Le Kremlin Bicêtre</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<affiliation><inist:fA14 i1="07"><s1>Pôle des maladies du système nerveux, Fédération de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Roze, Emmanuel" sort="Roze, Emmanuel" uniqKey="Roze E" first="Emmanuel" last="Roze">Emmanuel Roze</name>
<affiliation><inist:fA14 i1="05"><s1>Commission Mouvements Anormaux, de la Société Française de Neurologie Pédiatrique</s1>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="07"><s1>Pôle des maladies du système nerveux, Fédération de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="12"><s1>Centre d'Investigation Clinique, 9503, INSERM, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="13"><s1>CNRS UMRS 952, INSERM UMR 7224, Université Pierre et Marie Curie Paris VI</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">10-0413281</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0413281 INIST</idno>
<idno type="RBID">Pascal:10-0413281</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000957</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Speech Disturbances in Patients With Dystonia or Chorea Due to Neurometabolic Disorders</title>
<author><name sortKey="Flamand Rouviere, Constance" sort="Flamand Rouviere, Constance" uniqKey="Flamand Rouviere C" first="Constance" last="Flamand-Rouviere">Constance Flamand-Rouviere</name>
<affiliation><inist:fA14 i1="01"><s1>Service de Neurologie, CHU de Bicêtre, AP-HP</s1>
<s2>Le Kremlin Bicêtre</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Guettard, Emilie" sort="Guettard, Emilie" uniqKey="Guettard E" first="Emilie" last="Guettard">Emilie Guettard</name>
<affiliation><inist:fA14 i1="02"><s1>Service de médecine physique et de réadaptation, Hôpital Fernand Widal, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Moreau, Caroline" sort="Moreau, Caroline" uniqKey="Moreau C" first="Caroline" last="Moreau">Caroline Moreau</name>
<affiliation><inist:fA14 i1="03"><s1>Service de neurologie et pathologie du mouvement, IMPRT, Lille EA 2683, IFR 114</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bahi Buisson, Nadia" sort="Bahi Buisson, Nadia" uniqKey="Bahi Buisson N" first="Nadia" last="Bahi-Buisson">Nadia Bahi-Buisson</name>
<affiliation><inist:fA14 i1="04"><s1>Service Neurologie Pédiatrique et Maladies métaboliques, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="05"><s1>Commission Mouvements Anormaux, de la Société Française de Neurologie Pédiatrique</s1>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Valayannopoulos, Vassili" sort="Valayannopoulos, Vassili" uniqKey="Valayannopoulos V" first="Vassili" last="Valayannopoulos">Vassili Valayannopoulos</name>
<affiliation><inist:fA14 i1="04"><s1>Service Neurologie Pédiatrique et Maladies métaboliques, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="06"><s1>Centre de Référence des Maladies Héréditaires du Métabolisme, Hôpital Necker Enfants Malades, Université Paris-Descartes</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Grabli, David" sort="Grabli, David" uniqKey="Grabli D" first="David" last="Grabli">David Grabli</name>
<affiliation><inist:fA14 i1="07"><s1>Pôle des maladies du système nerveux, Fédération de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Motte, Jacques" sort="Motte, Jacques" uniqKey="Motte J" first="Jacques" last="Motte">Jacques Motte</name>
<affiliation><inist:fA14 i1="08"><s1>Unité de neurologie pédiatrique, American Memorial Hospital, CHU Reims</s1>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rodriguez, Diana" sort="Rodriguez, Diana" uniqKey="Rodriguez D" first="Diana" last="Rodriguez">Diana Rodriguez</name>
<affiliation><inist:fA14 i1="09"><s1>Service de neuropédiatrie, Université Pierre et Marie Curie, Paris VI, Hôpital Armand Trousseau, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Roubertie, Agathe" sort="Roubertie, Agathe" uniqKey="Roubertie A" first="Agathe" last="Roubertie">Agathe Roubertie</name>
<affiliation><inist:fA14 i1="10"><s1>Service de Neurologie Pédiatrique, CHU</s1>
<s2>Montpellier</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Maintigneux, Lisa" sort="Maintigneux, Lisa" uniqKey="Maintigneux L" first="Lisa" last="Maintigneux">Lisa Maintigneux</name>
<affiliation><inist:fA14 i1="01"><s1>Service de Neurologie, CHU de Bicêtre, AP-HP</s1>
<s2>Le Kremlin Bicêtre</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kemlin, Isabelle" sort="Kemlin, Isabelle" uniqKey="Kemlin I" first="Isabelle" last="Kemlin">Isabelle Kemlin</name>
<affiliation><inist:fA14 i1="09"><s1>Service de neuropédiatrie, Université Pierre et Marie Curie, Paris VI, Hôpital Armand Trousseau, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ceballos Picot, Irene" sort="Ceballos Picot, Irene" uniqKey="Ceballos Picot I" first="Irène" last="Ceballos-Picot">Irène Ceballos-Picot</name>
<affiliation><inist:fA14 i1="11"><s1>Service de Biochimie Métabolique, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Adams, David" sort="Adams, David" uniqKey="Adams D" first="David" last="Adams">David Adams</name>
<affiliation><inist:fA14 i1="01"><s1>Service de Neurologie, CHU de Bicêtre, AP-HP</s1>
<s2>Le Kremlin Bicêtre</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<affiliation><inist:fA14 i1="07"><s1>Pôle des maladies du système nerveux, Fédération de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Roze, Emmanuel" sort="Roze, Emmanuel" uniqKey="Roze E" first="Emmanuel" last="Roze">Emmanuel Roze</name>
<affiliation><inist:fA14 i1="05"><s1>Commission Mouvements Anormaux, de la Société Française de Neurologie Pédiatrique</s1>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="07"><s1>Pôle des maladies du système nerveux, Fédération de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="12"><s1>Centre d'Investigation Clinique, 9503, INSERM, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="13"><s1>CNRS UMRS 952, INSERM UMR 7224, Université Pierre et Marie Curie Paris VI</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Chorea</term>
<term>Dystonia</term>
<term>Human</term>
<term>Nervous system diseases</term>
<term>Speech</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Dystonie</term>
<term>Syndrome choréique</term>
<term>Pathologie du système nerveux</term>
<term>Parole</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Speech disturbances are frequent and potentially disabling in patients with dystonia or chorea due to neurometabolic disorders (DCND), but their precise characteristics are poorly documented. We prospectively studied 29 consecutive patients with DCND. A detailed description of their speech patterns was obtained by using the Frenchay dysarthria assessment test and the apraxia of speech evaluation test of Wertz. Gross motor function and intelligibility were each scored on 5-point scales to identify a possible correlation between the severity of the speech and motor disorders. All the patients were found to have complex speech alterations with combined features of hyperkinetic dysarthria and speech apraxia. We also noted a correlation between the severity of the speech disorders and the motor disorders. These findings have important implications for speech rehabilitation, and may provide new insights into the pathophysiology of dystonia due to neurometabolic disorders.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>25</s2>
</fA05>
<fA06><s2>11</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Speech Disturbances in Patients With Dystonia or Chorea Due to Neurometabolic Disorders</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>FLAMAND-ROUVIERE (Constance)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>GUETTARD (Emilie)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>MOREAU (Caroline)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>BAHI-BUISSON (Nadia)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>VALAYANNOPOULOS (Vassili)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>GRABLI (David)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>MOTTE (Jacques)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>RODRIGUEZ (Diana)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>ROUBERTIE (Agathe)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>MAINTIGNEUX (Lisa)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>KEMLIN (Isabelle)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>CEBALLOS-PICOT (Irène)</s1>
</fA11>
<fA11 i1="13" i2="1"><s1>ADAMS (David)</s1>
</fA11>
<fA11 i1="14" i2="1"><s1>VIDAILHET (Marie)</s1>
</fA11>
<fA11 i1="15" i2="1"><s1>ROZE (Emmanuel)</s1>
</fA11>
<fA14 i1="01"><s1>Service de Neurologie, CHU de Bicêtre, AP-HP</s1>
<s2>Le Kremlin Bicêtre</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Service de médecine physique et de réadaptation, Hôpital Fernand Widal, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Service de neurologie et pathologie du mouvement, IMPRT, Lille EA 2683, IFR 114</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Service Neurologie Pédiatrique et Maladies métaboliques, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Commission Mouvements Anormaux, de la Société Française de Neurologie Pédiatrique</s1>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Centre de Référence des Maladies Héréditaires du Métabolisme, Hôpital Necker Enfants Malades, Université Paris-Descartes</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Pôle des maladies du système nerveux, Fédération de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Unité de neurologie pédiatrique, American Memorial Hospital, CHU Reims</s1>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Service de neuropédiatrie, Université Pierre et Marie Curie, Paris VI, Hôpital Armand Trousseau, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="10"><s1>Service de Neurologie Pédiatrique, CHU</s1>
<s2>Montpellier</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="11"><s1>Service de Biochimie Métabolique, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="12"><s1>Centre d'Investigation Clinique, 9503, INSERM, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="13"><s1>CNRS UMRS 952, INSERM UMR 7224, Université Pierre et Marie Curie Paris VI</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>15 aut.</sZ>
</fA14>
<fA20><s1>1605-1611</s1>
</fA20>
<fA21><s1>2010</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000192608100110</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2010 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>35 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>10-0413281</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Speech disturbances are frequent and potentially disabling in patients with dystonia or chorea due to neurometabolic disorders (DCND), but their precise characteristics are poorly documented. We prospectively studied 29 consecutive patients with DCND. A detailed description of their speech patterns was obtained by using the Frenchay dysarthria assessment test and the apraxia of speech evaluation test of Wertz. Gross motor function and intelligibility were each scored on 5-point scales to identify a possible correlation between the severity of the speech and motor disorders. All the patients were found to have complex speech alterations with combined features of hyperkinetic dysarthria and speech apraxia. We also noted a correlation between the severity of the speech disorders and the motor disorders. These findings have important implications for speech rehabilitation, and may provide new insights into the pathophysiology of dystonia due to neurometabolic disorders.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17H</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Dystonie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Dystonia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Distonía</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Syndrome choréique</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Chorea</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Corea síndrome</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Pathologie du système nerveux</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Parole</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Speech</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Habla</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Homme</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Human</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Hombre</s0>
<s5>10</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Pathologie du muscle strié</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Striated muscle disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Músculo estriado patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Pathologie du système nerveux central</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>43</s5>
</fC07>
<fN21><s1>270</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 10-0413281 INIST</NO>
<ET>Speech Disturbances in Patients With Dystonia or Chorea Due to Neurometabolic Disorders</ET>
<AU>FLAMAND-ROUVIERE (Constance); GUETTARD (Emilie); MOREAU (Caroline); BAHI-BUISSON (Nadia); VALAYANNOPOULOS (Vassili); GRABLI (David); MOTTE (Jacques); RODRIGUEZ (Diana); ROUBERTIE (Agathe); MAINTIGNEUX (Lisa); KEMLIN (Isabelle); CEBALLOS-PICOT (Irène); ADAMS (David); VIDAILHET (Marie); ROZE (Emmanuel)</AU>
<AF>Service de Neurologie, CHU de Bicêtre, AP-HP/Le Kremlin Bicêtre/France (1 aut., 10 aut., 13 aut.); Service de médecine physique et de réadaptation, Hôpital Fernand Widal, AP-HP/Paris/France (2 aut.); Service de neurologie et pathologie du mouvement, IMPRT, Lille EA 2683, IFR 114/France (3 aut.); Service Neurologie Pédiatrique et Maladies métaboliques, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP/Paris/France (4 aut., 5 aut.); Commission Mouvements Anormaux, de la Société Française de Neurologie Pédiatrique/France (4 aut., 15 aut.); Centre de Référence des Maladies Héréditaires du Métabolisme, Hôpital Necker Enfants Malades, Université Paris-Descartes/Paris/France (5 aut.); Pôle des maladies du système nerveux, Fédération de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP/Paris/France (6 aut., 14 aut., 15 aut.); Unité de neurologie pédiatrique, American Memorial Hospital, CHU Reims/France (7 aut.); Service de neuropédiatrie, Université Pierre et Marie Curie, Paris VI, Hôpital Armand Trousseau, AP-HP/Paris/France (8 aut., 11 aut.); Service de Neurologie Pédiatrique, CHU/Montpellier/France (9 aut.); Service de Biochimie Métabolique, Hôpital Necker Enfants Malades, Université Paris-Descartes, AP-HP/Paris/France (12 aut.); Centre d'Investigation Clinique, 9503, INSERM, AP-HP/Paris/France (15 aut.); CNRS UMRS 952, INSERM UMR 7224, Université Pierre et Marie Curie Paris VI/Paris/France (15 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2010; Vol. 25; No. 11; Pp. 1605-1611; Bibl. 35 ref.</SO>
<LA>Anglais</LA>
<EA>Speech disturbances are frequent and potentially disabling in patients with dystonia or chorea due to neurometabolic disorders (DCND), but their precise characteristics are poorly documented. We prospectively studied 29 consecutive patients with DCND. A detailed description of their speech patterns was obtained by using the Frenchay dysarthria assessment test and the apraxia of speech evaluation test of Wertz. Gross motor function and intelligibility were each scored on 5-point scales to identify a possible correlation between the severity of the speech and motor disorders. All the patients were found to have complex speech alterations with combined features of hyperkinetic dysarthria and speech apraxia. We also noted a correlation between the severity of the speech disorders and the motor disorders. These findings have important implications for speech rehabilitation, and may provide new insights into the pathophysiology of dystonia due to neurometabolic disorders.</EA>
<CC>002B17; 002B17H</CC>
<FD>Dystonie; Syndrome choréique; Pathologie du système nerveux; Parole; Homme</FD>
<FG>Syndrome extrapyramidal; Mouvement involontaire; Pathologie du muscle strié; Trouble neurologique; Pathologie de l'encéphale; Pathologie du système nerveux central</FG>
<ED>Dystonia; Chorea; Nervous system diseases; Speech; Human</ED>
<EG>Extrapyramidal syndrome; Involuntary movement; Striated muscle disease; Neurological disorder; Cerebral disorder; Central nervous system disease</EG>
<SD>Distonía; Corea síndrome; Sistema nervioso patología; Habla; Hombre</SD>
<LO>INIST-20953.354000192608100110</LO>
<ID>10-0413281</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000957 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000957 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:10-0413281 |texte= Speech Disturbances in Patients With Dystonia or Chorea Due to Neurometabolic Disorders }}
This area was generated with Dilib version V0.6.23. |